Lipomed   Report issue

For profit Phase 2 Phase 3
Founded: Arlesheim Switzerland (1993)
Status: No NME R&D (1993)

Organization Overview

First Clinical Trial
2002
NCT00350662
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now